Advocacy / AMAC Action's Response / AMAC On Capitol Hill / Coronavirus / Healthcare / Support Letters

AMAC Supports Bill to Expand Technologies for US Pharmaceutical Manufacturing

The AMAC Action Government Relations Team was recently contacted by the office of Senator Marsha Blackburn (R-TN) to review her and co-sponsor Senator Bob Menendez’s (D-NJ) bill to address the foreign manufacturing, specifically Chinese, of active ingredients for pharmaceutical products used in the United States. Among other initiatives, the bill would bring this manufacturing back to the United States by expanding the Food and Drug Administration’s Emerging Technologies Program to speed technologies that would address drug shortages and create a skilled pharmaceutical manufacturing workforce in America. AMAC members have voiced their support for breaking American dependence on Chinese pharmaceuticals and AMAC Action is proud to support this bill on their behalf.

April 21, 2020

The Honorable Marsha Blackburn          The Honorable Bob Menendez

357 Dirksen Senate Office Building         528 Hart Senate Office Building

Washington, DC 20510                                Washington, DC 20510

Dear Senators Blackburn and Menendez,

On behalf of our more than 2.1 million members, the Association of Mature American Citizens (AMAC) is writing in support of the Securing America’s Medicine Cabinet (SAM-C) Act of 2020, S. 3432. This bipartisan legislation would reduce American reliance on foreign manufacturing of active pharmaceutical ingredients (APIs). An increase in American-based pharmaceutical production would make for a healthier America.

APIs are an essential component for finished prescription drugs, many of which are prescribed for mature Americans to help promote both good health and quality of life. However, only 28 percent of API producing facilities are located in America. The U.S. has become increasingly dependent upon China, a country lacking effective manufacturing safety regulations and oversight, for prescription drugs. In the past, Americans have been put at risk for contaminated drugs and drug shortages. As a result of the coronavirus pandemic, it has become abundantly clear America must rely on its own resources to stay safe and healthy.

This legislation would expand the U.S. Food and Drug Administration’s (FDA) Emerging Technology Program to develop technologies that can address replenishing the national strategic stockpile, eliminate critical drug shortages, and create pharmaceutical manufacturing jobs at home by ensuring that the workforce has the necessary training needed to innovate new APIs on U.S. soil. AMAC unequivocally supports addressing dangerous drug shortages as well as eliminating the threat of harmful imported medicines.

The SAM-C Act would bring drug manufacturing back to the United States, securing citizens have better access to medication they need. AMAC appreciates the bipartisan efforts by Senator Marsha Blackburn (R-TN) and Senator Bob Menendez (D-NJ) for introducing this important legislation. AMAC is proud to support S. 3432, a bill that strengthens the American pharmaceutical supply chain and prioritizes the safety of U.S. citizens.

Sincerely,

Bob Carlstrom

President

AMAC Action

Read Support Letter

If You Enjoy Articles Like This - Subscribe to the AMAC Daily Newsletter!

Sign Up Today
Subscribe
Notify of
9 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments
J kasdorf
3 months ago

I have said for years, you want manufacturing of all types to move back to this country, give them enough incentives. Let them be tax free for a few years or have them pay 1/4 of the taxes that the government requires. Ship their equipment back here for free. I’m sure there are many company’s who would like to remove the “ made in China “ tag from their products.

Jo Nelson
3 months ago

we need to bring every product or innovation we have in China back to USA. We have become weak economically because of these deals.

E. Fletcher
3 months ago

Boycott, boycott, boycott. Just tell your pharmacist that you will not accept any medication manufactured in China. Having worked in medical, I’ve seen what their contaminated medications have done: contaminated heparin, losartan, irbesartan, digitalis. If our pharmaceutical big wigs won’t do it, WE THE PEOPLE can. China has even poisoned our pets with a contaminated dog food ingredient and now contaminated chicken jerky treats. I’ve been boycotting Chinese produced medication for 14 years WHY, WHY, WHY are we doing business with this COMMUNIST country. It’s obvious they have no respect, compassion, integrity or honor for anything or anybody except their… Read more »

Joanna Johnson-Smith
3 months ago

Get our vital medicines OUT of the Communist Hands? Giving them the power to kill millions is not exactly intelligent!! We need the jobs here, we need the quality control HERE, and we should NEVER be dependent on an enemy of America!

Paul Lorentz
3 months ago

This should not be limited to the ACTIVE ingredients. The other ingredients are more important that is generally known.

Paul Lorentz
3 months ago

All pharmaceuticals should be labeled with the country of origin. Including those made with foreign components.

Sue Zanna Mitchell
3 months ago

This is an over due move for USA – we as a nation CANNOT be dependant on China for our medicines, food, or the manufacturing of our needed staples.Over & over again, China leadership has proven to be dishonest, untrustworthy. We must break totally any dependency on them. Thank you.

9
0
Would love your thoughts, please comment.x
()
x